高分辨率CT特征、炎症水平与肺炎支原体肺炎患儿急性期诱导痰病原菌负荷的关系

doi:10.20274/j.cnki.issn.1674-3865.2026.01.016

Abstract

Abstract:

Objective To investigate the relationship of high-resolution computed tomography(HRCT) features and serum inflammatory levels with the pathogen load in induced sputum of children with Mycoplasma pneumoniae pneumonia（MPP） during the acute phase. Methods One hundred children diagnosed with MPP who were treated at our hospital from March 2020 to March 2023 were enrolled in the study. All subjects underwent HRCT and quantitative measurement of Mycoplasma pneumoniae DNA copy number in induced sputum. Based on a threshold of 10⁶ copies/mL, patients were assigned to a low-load group(≤10⁶ copies/mL; n=42) or a high-load group(>10⁶ copies/mL; n=58). HRCT features, serum levels of inflammatory factors and related Th1/Th2 transcription factors were compared between groups, and the relationship between each indicator and the pathogen load was explored. Results Compared with the low-load group, the high-load group showed significantly higher incidence of air bronchogram, pulmonary consolidation, and lobar consolidation on HRCT(all P<0.05). The levels of serum sTREM?1 and sICAM?1 were higher in the high-load group than in the low-load group, while hBD?1 was lower(P<0.05); hBD?2 level did not differ between the two groups(P>0.05). The expressions of T-bet mRNA and GATA3 mRNA were higher in the high-load group than in the low-load group, while the expressions of SOCS1 mRNA and SOCS3 mRNA were lower, the differences being statistically significant(P<0.05). Point-biserial correlation analysis showed that air bronchogram（r=0.697）, pulmonary consolidation（r=0.544）, and lobar consolidation（r=0.631） were positively correlated with pathogen load(P<0.05). Pearson correlation analysis revealed that sTREM-1, sICAM-1, T-bet mRNA, and GATA3 mRNA were positively correlated with pathogen load（r=0.651，0.654，0.647，0.654，P<0.001）, whereas hBD-1, SOCS1 mRNA, and SOCS3 mRNA were negatively correlated（r=-0.452，-0.655，-0.656，P<0.001）. Logistic regression analysis indicated that air bronchogram, lobar consolidation, and elevated sTREM-1 were independent risk factors for high pathogen load. Conclusion During acute phase of MPP, specific HRCT phenotypes are significantly associated with Mycoplasma pneumoniae pathogen load, and are closely related to the expressions of sTREM?1, sICAM?1 and Th1/Th2 transcription factors, which may provide auxiliary evidence for disease severity assessment and individualized management.

Key words: Mycoplasma pneumoniae pneumonia, Acute phase, High-resolution CT, Inflammatory factors, Pathogen load

CLC Number:

R725.6

Linlin DU, Jun LI, Cancan XU. Correlation of high‐resolution CT features and serum inflammatory levels with induced-sputum pathogen load in children with Mycoplasma pneumoniae pneumonia during acute phase[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 82-87.

Figures/Tables 4

Table 1

Table 2

Table 3

Table 4

References 30

[1]	Xiong S, Lin L, Chen Q, et al. Construction and validation of a nomogram model to predict bronchiolitis Mycoplasma pneumoniae pneumonia in children[J]. Sci Rep, 2024, 14(1): 30758.
[2]	Ding G, Zhang X, Vinturache A, et al. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia[J]. Eur J Pediatr, 2024, 183(7): 3001-3011.
[3]	Wang Y, Yu X, Liu F, et al. Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia[J]. Emerg Microbes Infect, 2023, 12(1): 2202272.
[4]	苏布德格日乐,刘伟民,斯琴格日勒,等.儿童肺炎支原体肺炎急性期高分辨率CT特征与血清炎症因子、病情严重程度及预后的相关性[J].放射学实践,2023,38(9):1173-1177.
[5]	Gao L, Sun Y. Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review[J]. Ann Med, 2024, 56(1): 2386636.
[6]	Wei H, Wang C, Ding L, et al. The diagnostic value of high-resolution computed tomography features combined with Mycoplasma pneumoniae ribonucleic acid load detection for refractory Mycoplasma pneumonia[J]. Contrast Media Mol Imaging, 2022, 2022: 6460865.
[7]	李淑,刘洪.2020—2022年阜南县儿童肺炎住院病例病原菌分布及耐药特征分析[J].华南预防医学,2023,49(3):358-360.
[8]	李菁,包军,鲍一笑,等.肺炎支原体肺炎患儿肺泡灌洗液病菌量及其与Th1/Th2细胞免疫应答的关系[J].临床儿科杂志,2015,33(8):681-685.
[9]	王天有, 申昆玲, 沈颖. 诸福棠实用儿科学[M]. 9版. 北京: 人民卫生出版社, 2022.
[10]	Huang X, Gu H, Wu R, et al. Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes[J]. Respir Med, 2024, 221: 107480.
[11]	Zhao JL, Wang X, Wang YS. Relationships between Th1/Th2 cytokine profiles and chest radiographic manifestations in childhood Mycoplasma pneumoniae pneumonia[J]. Ther Clin Risk Manag， 2016，12:1683-1692.
[12]	Li W, Liu YJ, Zhao XL, et al. Th1/Th2 Cytokine Profile and Its Diagnostic Value in Mycoplasma pneumoniae Pneumonia[J]. Iran J Pediatr， 2016，26(1):e3807.
[13]	Zhang H, Sun C, Yu Z. Effect of azithromycin sequential therapy combined with budesonide nebulization on chest CT changes in children with Mycoplasma pneumonia[J]. Minerva Gastroenterol (Torino), 2023, 69(3): 447-449.
[14]	于程程,黄姗姗,王晨,等.高分辨率CT诊断小儿肺炎支原体肺炎的临床价值分析[J].影像研究与医学应用,2025,9(1):112-114.
[15]	蒲海波,刘亚丽,王菁,等.急性期支原体肺炎患儿HRCT影像特点及与肺通气、炎症参数和预后的相关性探究[J].中国临床医学影像杂志,2025,36(6):408-411.
[16]	Wang H, Zhao L, Yang Y, et al. Chest computed tomography radiomics for determining macrolide resistance-associated gene mutation status in children with Mycoplasma pneumoniae pneumonia: a two-center study[J]. Acad Radiol, 2024, 31(9): 3774-3782.
[17]	Xu W, Wang H, Wen X, et al. Risk factors for bronchiolitis obliterans development in children after Mycoplasma pneumoniae pneumonia: a retrospective study of 981 patients[J]. Ital J Pediatr， 2025，51(1):105.
[18]	Song Z, Jia G, Luo G, et al. Global research trends of Mycoplasma pneumoniae pneumonia in children: a bibliometric analysis[J]. Front Pediatr, 2023, 11: 1306234.
[19]	Xu W, Zhang X, Guan Y, et al. Clinical and CT characteristics of human metapneumovirus-associated severe pneumonia in children in Beijing[J]. Ital J Pediatr， 2025，51(1):136.
[20]	Xu M, Li Y, Shi Y, et al. Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020-2022[J]. BMC Microbiol， 2024，24(1):23.
[21]	Qi J, Jia F, Tian H, et al. Efficacy of gamma globulin combined with azithromycin sequential therapy in the treatment of RMPP and its effect on Th1/Th2 cytokine levels[J]. Comput Math Methods Med， 2022，2022:5162768.
[22]	何金泽,冯小玲,唐燕玉,等.Th1/Th2免疫应答平衡与肺炎支原体肺炎患者支原体抗体滴度及预后的关系探讨[J].传染病信息,2024,37(3):249-254.
[23]	李佳,杨保昌,郑双双.调节性T细胞转录因子T-bet、GATA-3失衡表达与重症肺炎患儿病情程度及预后的关系[J].临床肺科杂志,2025,30(3):377-382.
[24]	Yang S, Lu S, Guo Y, et al. A comparative study of general and severe mycoplasma pneumoniae pneumonia in children[J]. BMC Infect Dis， 2024，24(1):449.
[25]	张丽娉,王金菊,郝贵亮. 儿童难治性肺炎支原体肺炎的临床特征和炎症性因子研究[J]. 中国小儿急救医学,2025,32(4):273-278.
[26]	王慧英,汤昱,董利利,等.儿童难治性肺炎支原体肺炎肺泡灌洗液病菌量与Th1/Th2细胞免疫应答的相关性研究[J].循证医学,2024,24(2):78-83.
[27]	Meng H, Wang TD, Zhuo LY, et al. Quantitative radiomics analysis of imaging features in adults and children Mycoplasma pneumonia[J]. Front Med (Lausanne)， 2024，11:1409477.
[28]	Zhu Y, Luo Y, Li L, et al. Immune response plays a role in Mycoplasma pneumoniae pneumonia[J]. Front Immunol, 2023, 14: 1189647.
[29]	Dong H, Du Z, Liao Y, et al. Role of the Notch ligand DLL4 in the immune response of children with Mycoplasma pneumoniae pneumonia[J]. Rev Inst Med Trop Sao Paulo， 2025，67:e65.
[30]	李娟,颜维孝,马如海.重症MPP患儿外周血Th1/Th2类细胞因子变化及对近期预后不良的预测分析[J].中国免疫学杂志,2023,39(10):2222-2226.

组别	n	支气管壁增厚		淋巴结肿大		支气管充气征		胸腔积液
组别	n	是	否	是	否	是	否	是	否
低负荷组	42	30(71.43)	12(28.57)	18(42.86)	24(57.14)	15(35.71)	27(64.29)	5(11.90)	37(88.10)
高负荷组	58	50(86.21)	8(13.79)	22(37.93)	36(62.07)	40(68.97)	18(31.03)	15(25.86)	43(74.14)
χ²值		3.325		0.246		10.882		2.966
P值		0.068		0.620		0.001		0.085
组别	n	肺实变影		小叶性实变影		节段性实变影		大叶性实变影
组别	n	是	否	是	否	是	否	是	否
低负荷组	42	28(66.67)	14(33.33)	20(47.62)	22(52.38)	18(42.86)	24(57.14)	8(19.05)	34(80.95)
高负荷组	58	53(91.38)	5(8.62)	25(43.10)	33(56.90)	30(51.72)	28(48.28)	25(43.10)	33(56.90)
χ²值		9.667		0.201		0.767		6.376
P值		0.002		0.654		0.381		0.012

组别	n	sTREM-1（μg/L）	sICAM-1（μg/L）	hBD-1（mg/L）	hBD-2（mg/L）
低负荷组	42	1.72±0.23	243.21±31.12	14.22±1.23	51.02±6.12
高负荷组	58	2.33±0.34	399.15±34.11	13.02±1.02	53.98±4.12
t值		-10.071	-23.399	5.323	-1.914
P值		<0.001	<0.001	<0.001	0.059

组别	n	T-betmRNA	GATA3mRNA	SOCS1mRNA	SOCS3mRNA
低负荷组	42	1.38±0.15	1.97±0.23	0.66±0.06	0.82±0.09
高负荷组	58	1.88±0.12	3.23±0.35	0.26±0.05	0.46±0.06
t值		-18.503	-20.351	36.286	23.996
P值		<0.001	<0.001	<0.001	<0.001

因素	Β值	SE值	OR值（95%CI）	P值
支气管充气征	1.050	0.420	2.858（1.255～6.509）	0.012
大叶性实变影	0.920	0.380	2.509（1.191～5.285）	0.015
肺实变影	0.620	0.360	1.859（0.918～3.764）	0.085
sTREM-1	0.980	0.290	2.664（1.509～4.704）	0.001
年龄	0.080	0.070	1.083（0.944～1.243）	0.253

Correlation of high‐resolution CT features and serum inflammatory levels with induced-sputum pathogen load in children with Mycoplasma pneumoniae pneumonia during acute phase

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 30

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Sen KONG, Liang ZHANG, Nan LIAO, Guang TU. Application research on risk factor analysis of severe Mycoplasma pneumoniae pneumonia in children based on random forest model [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 71-76.
[2]	Jiayu LI, Yuan SUN, Xin FENG, Ke CHANG. Experience of Professor Chang Ke in treating damp-heat syndrome of mycoplasma pneumoniae pneumonia in children with the method of dredging obstruction and resolving turbidity(Xuanbi Huazhuo) [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(5): 442-446.
[3]	SHEN Hongyan, ZHANG Xiuying, TAN Chunying, SHANG Tao, MENG Bin, MU Jingwen, TIAN Zhifan, E Mingxin, WANG Xuefeng. A multi center clinical study on the adjuvant treatment with Fuxiong powder for children with Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(2): 93-98.
[4]	WU Pan, HUANG Tingyue, ZHANG Zhanling, WANG Xuefeng. Meta analysis and GRADE evaluation of Xiaoer Feire Kechuan oral liquid in the treatment of Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(2): 98-108.
[5]	KONG Xinyue, WANG Xuefeng, WANG Yulin. Analysis of the distribution of traditional Chinese medicine constitution and susceptible risk factors of severe Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2024, 16(6): 495-499.
[6]	QU Shengyue, MU Jingwen, YANG Jianshu, ZHAO Hangyu, ZHANG Xiuying, WANG Xuefeng. Clinical efficacy observation of Xiaoer Kechuanling oral solution (concentrated) in the treatment of Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2024, 16(5): 431-435.
[7]	ZHOU Tao, ZHANG Xiuying, WANG Xuefeng, WANG Yongxue, ZHAO Hangyu, WEI Chenhao. Effects of Dingchuan granules on viral load and airway resistance in lung tissue of young rats with respiratory syncytial virus pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2024, 16(1): 26-30.
[8]	ZHANG Songlin, GUO Yanjun, FENG Risheng. Significances of detection of T cell subsets，IgE and RANTES in infants with refractory Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2023, 15(3): 229-232.
[9]	SU Yonghong, SUN Xueli, YANG Lili, YAN Wenjuan, WU Chunlian. Risk factors of myocardial damage in children with Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(4): 323-325.
[10]	LIAN Chaoyu, XU Guangming, YAN Yanjie, YANG Junge. Relationship between disease severity and levels of vitamin D,C-reactive protein and D-dimer in children with Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(3): 225-228.
[11]	YAN Qiuli, HAO Chuangli. Clinical study of bronchoscopy intervention at different time points for children with refractory Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(2): 138-141.
[12]	YUAN Xiaoxu, JIA Chunmei. The clinical significance of D-dimer level in children with severe Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(1): 29-32.
[13]	LI Gang, HAN Xue. Professor Han Xue′s experience in treating refractory Mycoplasma pneumoniae pneumonia in children based on the theory of Qi deficiency [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(1): 76-79.
[14]	WEI Yuhui, LI Ruishi, HE Si, FENG Zhaocai. Theoretical mechanism of "Tiaofu Tongluo" combined probiotics in improving brain injury sequelae in neonatal [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(6): 476-479.
[15]	YANG Ying, LIU Yakun, DONG Tianjin. Expressions of serum sICAM-1 and CD40L in children with Mycoplasma pneumoniae pneumonia and their correlation with prognosis [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(6): 488-492.